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Hepcidin is a small acute phase peptide that regulates iron absorption. It is induced by inﬂammation
and infection, but is repressed by anaemia and hypoxia. Here we further reveal that hepcidin tran-
scription also involves interactions between functional metal response elements (MREs) in its pro-
moter, and the MRE-binding transcription factor-1. Analysis of hepcidin mRNA and protein levels in
hepatoma cells suggests that its expression may be regulated by divalent metal ions, with zinc
inducing maximal effects on hepcidin levels. These data suggest that this peptide may be a pleiotro-
pic sensor of divalent metals, some of which are xenobiotic environmental toxins.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Iron and zinc are two of the most abundant metals found in the
body, and appear to reciprocally affect each other’s bioavailability
and absorption. In humans, non-heme iron has been shown to re-
duce zinc uptake in the intestine [1,2]. Conversely, zinc reduces
intestinal iron uptake in rats and mice [3]; its inhibitory effects
on liver and splenic iron stores have also been observed in rats
fed a high zinc diet [4]. In addition, in vitro studies have demon-
strated that iron and zinc, as well as other divalent metals such
as copper inhibit each other’s uptake [5–7]. The interactions and
plasma concentrations of both metals are also inﬂuenced by infec-
tion and inﬂammation [8]. Their absorption is tightly regulated at
the molecular level by transporters at the apical and basolateral
surfaces of epithelial cells in the intestine. These transport proteins
include zinc–iron regulated transporter-like proteins (ZIPs) or
Slc39a family members which function in intracellular uptake of
zinc uptake and other metals. A second group of zinc transporters
consists of members of the solute carrier 30A (Slc30a) family or
ZnTs whose role is in zinc efﬂux and compartmentalizationchemical Societies. Published by E
F-1, MRE-binding transcrip-
say; bgal, beta-galactosidase;
ia).
Free and University College
, United Kingdom.[9,10]. In plants, the ZIP proteins have broad substrate speciﬁcity
and have also been shown to transport iron [11–13]. Both mice
and humans have 14 ZIP isoforms [14,15]; ZIP1 and ZIP2 have been
identiﬁed as zinc transporters [16–18].
Iron uptake into enterocytes occurs via divalent metal trans-
porter-1 (DMT-1), in a proton-dependent manner [19]. DMT1 is
found on the apical surface of enterocytes but is localized in intra-
cellular vesicles in other cell types, from where it transports iron
into the cytoplasm [20–22]. While DMT1 has broad substrate spec-
iﬁcity and was initially thought to transport zinc, studies have
shown that although DMT1 mRNA and protein are up-regulated
by zinc, a distinct uptake pathway exists for both iron and zinc
[23–26]. On the other hand, iron export from cells occurs via the
basolateral transporter, ferroportin [27–29]. Hepcidin, a liver-de-
rived peptide regulates body iron stores by inhibiting dietary iron
absorption, and by inducing the internalisation and degradation of
ferroportin [30,31].
The control of hepcidin expression is increasingly complex
because of the large number of effectors of its expression [32];
however, the mechanism for its transcriptional regulation by
iron remains elusive. We proposed that in addition to interaction
between iron and zinc at the cellular level, zinc might regulate
iron uptake and efﬂux by regulating expression of hepcidin. In
support of this we show here that MTF-1 a divalent metal ion
sensitive transcription factor, regulates hepcidin transcription
by binding to its cognate response elements within the hepcidin
promoter.lsevier B.V. All rights reserved.
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2.1. Promoter construct
Approximately 1.8 kb of the human hepcidin promoter was
ampliﬁed from placental genomic DNA with primers CAT GGT
ACC AAC ATC CCC GGG CTC TGG TGA CT (sense) and CAT CTC
GAG CGA GGA GGA GGA GGA GCA (antisense); primers were de-
signed based Acc # AD000684 (MWG Biotech, Ebersberg, Ger-
many). The PCR products were digested with KpnI–XhoI (New
England Biolabs, Hitchin, UK) (sites underlined), puriﬁed with
Geneclean (BIO101) and ligated into KpnI–XhoI-restricted pGL3
Basic vector (Promega) using the Quick ligation kit (NEB) to gener-
ate HepcP1.8-luc.
2.2. Site-directed mutagenesis of MREs
HepcP1.8-luc was subjected to site-directed mutagenesis using
the QuikChange Multi Site-Directed Mutagenesis system (Strate-
gene, Amsterdam, The Netherlands) as instructed by the manufac-
turer. Mutagenic primers (mutations in lowercase) were as
follows: MRE1/2 (incorporating a XhoI site), TTG ATC CCC TGG
GCC aTc Tcg AgC gTG AGC TGG GCC TGG T; MRE3 (incorporating
a BglII site), CTG TCA CCC AGG CTG cAG atC tGT CAC ACA ATC
ATA GCc c; MRE4 (incorporating a XbaI site), GCT GCT GGC CAT
GCC CCa TcT agA TGT AGG CGA TGG GGA. After initial denaturation
for 1 min at 95 C, PCR cycling parameters were 95 C (1 min),
55 C (1 min), and 65 C (12 min), for a total of 30 cycles. Following
DpnI digestion of wild-type HepcP1.8-luc, transformation of XL10
Gold cells with the mutagenesis reaction and selection on Luria-
Bertani agar/ampicillin plates, plasmid DNA was puriﬁed from
overnight cultures of single colonies and restricted with XhoI, BglII
and XbaI (Promega, UK) to identify colonies containing the relevant
mutation. The resulting mutant promoter constructs were desig-
nated D1/2, D3, D4, and D1/2, 3, 4 for mutants of MRE1/2,
MRE3, MRE4 and MRE1/2, 3, 4, respectively.
2.3. Cell culture, transfection, and reporter assays
All cell culture reagents were obtained from Invitrogen. Huh7
hepatoma cells were obtained from the UCL Institute of Hepatology
(United Kingdom) and baby hamster kidney (BHK) cells were
kindly provided by Jill Norman, University College London. The
cells were cultured in Dulbecco’s Minimal Essential Medium
(DMEM) with Earle salts and supplemented with non-essential
amino acids, 10% fetal bovine serum, and antibiotics; cells were
grown under standard cell-culture conditions. Transfection assays
were performed with BHK cells due to their attenuated MT-1
(metallothionein-1) expression, whereas Huh7 cells were used
for mRNA analysis of hepcidin because they constitutively express
MT-1. Hence for transfections, 104 BHK cells were seeded in each
well of Costar 24-well plates (Corning, Cambridge, MA). Approxi-
mately 100 ng of MTF-1 expression plasmid (kindly provided by
Glen Andrews, University of Kansas Medical Center), were diluted
in OptiMEM 1 and co-transfected with 100 ng HepcP1.8-luc or its
derivatives (site-directed mutants). All transfections were per-
formed and analysed as previously described [32].
2.4. Preparation of nuclear extracts and electrophoretic mobility shift
assay (EMSA)
Huh7 cells were harvested at log phase of growth by trypsiniza-
tion,washed twicewith phosphate-buffered saline, and resuspended
in lysisbuffer (10 mMHEPES(pH7.9), 1.5 mMMgCl2, 10 mMKCl, and
1 mMDTT) supplemented with Complete protease inhibitor cocktail(Roche, Lewes, United Kingdom). Nuclear extractswere prepared and
EMSA was performed as previously described [33]. We synthesized
two complementary oligonucleotides encompassingMRE1/2 (under-
lined) as follows: GATCCCTGGGCCGTGTGCACCCTGAGCTGGGC and
GCCCAGCTCAGGGTGCACACGGCCCAGGGATC; a mutant MRE oligo-
nucleotide (CCCTGGATTAGCCCGGGGGCAAGC)was also synthesized.
For competitive inhibition, a 100-fold molar excess of the cold MRE
oligonucleotidewasadded to thebinding reaction10 minbefore add-
ing the labeled probe.
2.5. Huh7 cell treatment, RNA extraction and RT-PCR
Huh7 cells were seeded onto 6-well plates (Nunc) at a density of
105 cells/well. At 90% conﬂuence, complete medium was re-
placed with serum-free medium supplemented with the appropri-
ate concentrations of metal. Cadmium was used at a much lower
concentration than the other metals due to its highly toxic nature.
Cells were washed with PBS, and RNA was extracted with TRIzol
(Invitrogen) according to the manufacturer’s instructions. Total
RNA (1 lg) was reverse transcribed using the Verso cDNA kit
(Thermoﬁsher Scientiﬁc), according to the manufacturer’s instruc-
tions. All reactions were performed in the Lightcycler (Roche) using
GAPDH as internal standard. Each reaction was performed in dupli-
cate and contained 10 pmoles of speciﬁc primers (Table 1), 1
SYBR Green Mastermix (Qiagen), and 1 ll of cDNA in a 20 ll reac-
tion. Samples without cDNA were included as negative controls.
Cycle threshold (Ct) values were obtained for each gene of interest
and the GAPDH internal standard. Gene expression was normal-
ized to GAPDH and represented as DCt values. For each sample
the mean of the DCt values was calculated. Relative gene expres-
sion was normalized to 1.0 (100%) of controls.
2.6. Hepcidin synthesis, refolding and antibody production
Human hepcidin (25-amino acids: DTHFPICIFCCGCCHRSKCG-
MCCKT) was synthesized. The lyophilised crude reduced hepcidin
(25 mg) peptide was dissolved in neat triﬂuoroacetic acid (30 ml)
and dried to a thin ﬁlm under vacuum for 24 h in a quick-ﬁt ﬂask,
using a rotary evaporator. To this dried ﬁlm, 50 ml of 0.1 M of de-
aerated ammonium bicarbonate was added and stirred for 48 h
open to the atmosphere for air oxidation; complete oxidation of
the peptide was ascertained with the Ellman reagent. The fully-
oxidised mixture was then puriﬁed by HPLC on Vydac columns,
and monitored by UV detection at 220 nm. Purity was checked
by MALDI-TOF; the molecular weight of the peptide was measured
as 2789 Da (Mr 2789.40). The peptide was next conjugated to key-
hole limpet hemocyanin by standard glutaldehyde reaction, mixed
with complete Freunds adjuvant and used to immunize rabbits.
Following three booster injections of the peptide in incomplete
Freunds adjuvant, antibody titre was monitored by ELISA.
2.7. SDS–PAGE and Western blotting
Huh7 cells either untreated or treated with zinc or cadmium
were lysed in RIPA buffer containing protease inhibitors (Sigma).
Cellular protein content was determined with the Pierce protein
assay system as instructed by the manufacturer; 50 lg aliquots
of homogenates were diluted with an equal volume of 2 Laemmli
sample buffer, heated at 40 C for 30 min and resolved on a 12%
polyacrylamide gel (Bio-Rad) at 40 mA. Proteins were transferred
onto 0.2 lm PVDF membranes (Bio-Rad), using a Bio-Rad Trans-
Blot SD semi-dry blotter. After transfer, the blots were washed in
distilled water (3  1 min) and incubated in 10% glutaraldehyde
overnight. After washing 3  5 min with distilled water, the mem-
brane was incubated with 5% non-fat dry milk in PBS-T (PBS/0.1%
Tween 20) overnight at 4 C, with gentle agitation. A 1:2000 dilu-
Table 1
Forward (FWD) and reverse (RVS) primers for human hepcidin, MT-1 and GAPDH
real-time RT-PCR.
Target Primer sequence (50 ? 30)
Human hepcidin FWD: CTGCAACCCCAGGACAGAG
RVS: GGAATAAATAAGGAAGGGAGGGG
Human MT- I FWD: ATGGACCCCAACTGCTCCTGC
RVS: GGCACAGCAGCTGCACTTCTC
Human GAPDH FWD: TGGTATCGTGGAAGGACTC
RVS: AGTAGAGGCAGGGATGATG
Fig. 2. Differential transactivation of the hepcidin promoter by divalent metals.
HepcP1.8-luc (100 ng) was transfected into BHK cells, along with 100 ng MTF-1.
Transfected cells were subsequently treated with various amounts of cadmium
(10 lM CdCl2); cobalt (100 lM CoCl2); copper (50 lM CuSO4); iron (50 lM FeSO4)
and zinc (100 lM ZnSO4). Fold activation was calculated with respect to the activity
of the hepcidin promoter alone. All transfections were performed in triplicate and
included pSVbgal as internal control; luciferase levels were normalized to bgal
activity. Two independent experiments were performed. Data are presented as
means ± S.E.M. *P < 0.05.
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again incubated overnight at 4 C. It was then washed 1  15 min
and then a further 3  5 min with PBS-T, and incubated with
HRP-conjugated donkey anti-rabbit IgG antibody (Amersham) for
1 h; signal detection employed the SuperSignal West Pico Western
blotting detection system (Pierce), and a Fluor-S MultiImager (Bio-
Rad). The membrane was also probed with a 1:20 000 dilution of
HRP-conjugated anti-actin antibody AC-15 (Abcam) to control for
equivalent sample loading.
3. Results
3.1. The hepcidin gene contains three functional consensus MRE motifs
Sequence analysis of HepcP1.8-luc revealed four putative con-
sensus MRE motifs (Fig. 1A). The most distal of these comprises
two overlapping MREs in reverse orientations. To test whether
these elements were functional, HepcP1.8-luc was co-transfected
with MTF-1 into BHK cells in which MT-1 genes are quiescent;
these cells therefore have a lower capacity to buffer intracellular
zinc, cadmium and copper, thus enabling the effects of extracellu-
lar zinc on hepcidin transcription to be assessed. We found a con-Fig. 1. Promoter region of the human hepcidin gene. (A) Spatial arrangement and
nucleotide sequences of the MREs (boxes) within the cloned human hepcidin gene
promoter. (B) Zinc transactivates the hepcidin promoter. HepcP1.8-luc (100 ng) was
transfected into BHK cells, along with 100 ng MTF-1. Transfected cells were
subsequently treated with various amounts of zinc (5, 50, 100 lM ZnSO4). Fold
activationwas calculatedwith respect to the activity of the hepcidin promoter alone.
All transfections were performed in triplicate and included pSVbgal as internal
control; luciferase levels were normalized to bgal activity. Data are representative of
two independent experiments and are presented as means ± S.E.M. *P < 0.05.centration-dependent increase in luciferase activity in transfected
BHK cells when zinc was added to the medium (Fig. 1B). This metal
induced over a 3-fold increase in luciferase activity compared to
non-treated control. Other metals such as cadmium and copper
have been shown to induce the transcription of genes that contain
MREs [34]. To address this, transfected BHK cells were treated with
both cadmium and copper. Luciferase activity in BHK cells trans-
fected with the hepcidin promoter construct and subsequently
treated with cadmium or copper showed a signiﬁcant increase in
luciferase expression (Fig. 2). However, this increase was minimal
at 1.5-fold and 1.3-fold for cadmium and copper, respectively. As
hepcidin is an iron regulatory gene and is also regulated by hypox-
ia, both iron and the hypoxia mimetic CoCl2 were added to the
medium of BHK cells co-transfected with HepcP1.8-luc and MTF-
1. Luciferase activity in those cells did not alter signiﬁcantly from
the non-treated controls.
3.2. Functional MREs are required for the MTF-1-dependent hepcidin
transcriptional response to zinc
Is the transcription of hepcidin by zinc and cadmium MTF-1-
dependent? To address this question, MTF-1 was omitted from
the transfection cocktail and luciferase activity assessed after me-
tal treatment. Omission of MTF-1 from the transfections abrogated
luciferase activity in response to zinc (Fig. 3). This effect was also
seen after the treatment of cells with cadmium. In order to deter-
mine whether the MREs present in the hepcidin promoter were
functional, point mutations were introduced into each MRE.
Mutating all four MREs diminished the zinc-speciﬁc luciferase
activity seen when all the MREs are intact (Fig. 4). This decrease
was approximately 3-fold compared to control. Mutation of each
individual MRE decreased zinc-mediated activity by approximately
2-fold. Mutation of MRE1/2 (see Fig. 1A) had a deleterious effect on
basal luciferase activity, reducing it approximately 2-fold com-
pared to wild-type promoter activity. These results suggest that
the MREs are functional and are critical to both the basal and
inducible expression of hepcidin by zinc.
3.3. Binding of MTF-1 to the hepcidin MREs
EMSA was performed to determine whether zinc- or cadmium-
treated cell extracts could bind to MREs in vitro (Fig. 5). Binding to
MRE1/2 was observed with extracts from both non-treated and
zinc-treated Huh7 cells (Fig. 5, lanes 2–4). Binding to MREs 3 and
Fig. 3. MTF-1 is essential for zinc- and cadmium-mediated activation of the human
hepcidin promoter. The cloned human hepcidin promoter (100 ng) was transfected
into BHK cells, with or without 100 ng MTF-1. Transfected cells were subsequently
treated with various amounts of cadmium (10 lM CdCl2) or zinc (100 lM ZnSO4).
Fold activation was calculated with respect to the activity of the hepcidin promoter
alone. All transfections were performed in triplicate and included pSVbgal as
internal control; luciferase levels were normalized to bgal activity. Data are
representative of two independent experiments and are presented as
means ± S.E.M.
Fig. 5. Promoter occupancy by MTF-1 in vitro. Huh7 cell nuclear extracts (10 lg)
treated with zinc (100 lM ZnSO4; lanes 3 and 6) or cadmium (10 lM CdCl2; lanes 4
and 7) for 6 h were incubated with radiolabelled MREs. Excess unlabeled or cold
competitor oligonucleotide (100 pmol) was added to the binding reactions where
indicated.
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(data not shown). This binding was speciﬁcally competed out
when an excess of cold probe was added (Fig. 5, lanes 5–7). These
data showed that the MREs in the hepcidin promoter are integral
to hepcidin transcriptional regulation by MTF-1.
3.4. Differential induction of hepcidin expression in hepatoma cells by
divalent metals
The addition of zinc, cadmium and copper to the media of Huh7
cells showed a marked increase in hepcidin mRNA levels relative to
control (Fig. 6A). This increase was highest with cadmium at
approximately 3.5-fold, although zinc and copper elicited a similar
response, increasing hepcidin mRNA levels by approximately 3-
fold each. As a positive control, we also assessed MT-1 levels and
found a concomitant increase in its mRNA in Huh7 cells treated
with the same metals. Zinc elicited the largest response with an
approximate 17-fold increase, with cadmium increasing MT-1
mRNA by approximately 5-fold and copper with a 3-fold increase.
Cobalt also elicited a signiﬁcant increase in MT-1 mRNA, although
this increase was only slightly above basal levels (Fig. 6B). This isFig. 4. Site-directed mutagenesis of MREs in the hepcidin promoter. Promoter
constructs were produced with mutations in MRE1/2 (D1/2), MRE3 (D3), MRE4
(D4), and in all MREs (D1/2, 3, 4). Basal activities of both mutant and wild-type
(WT) promoters were compared with zinc treated after transfection in BHK cells
with MTF-1 (100 ng). All transfections were performed in triplicate and included
pSVbgal as internal control; luciferase levels were normalized to bgal activity. Two
independent experiments were performed. Data are presented as means ± S.E.M. A
statistically signiﬁcant difference (P < 0.05) is indicated by a different letter above
the bar.not surprising as MT-1 has been shown to bind many divalent met-
als, including cobalt [35,36]. Notably, cobalt chloride (a hypoxia
mimetic) decreased hepcidin mRNA levels 5-fold supporting obser-
vations that hypoxia down-regulates hepcidin expression. Also
consistent with previous observations, iron caused a marked de-Fig. 6. Hepcidin and MT-1 mRNA expression in Huh7 cells. Q-PCR analysis of (A)
hepcidin and (B) MT-1 mRNA expression in Huh7 cells. Cells were treated with
cadmium (10 lM CdCl2); cobalt (100 lM CoCl2); copper (50 lM CuSO4); iron
(50 lM FeSO4) and zinc (100 lM ZnSO4) for 6 h. All treatments were performed in
duplicate with two independent experiments being performed. Data are presented
as means ± S.E.M.
Fig. 7. Western blotting. Hepcidin expression at the protein level was determined
with Huh7 cells either untreated (control) or treated with cadmium (10 lM CdCl2)
for 6 h or with zinc (100 lM ZnSO4) for 6 and 24 h.
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crease in MT-1 mRNA levels.
To ascertain whether hepcidin mRNA was in fact translated fol-
lowing induction with metals, we performed Western blotting
with extracts of Huh7 cells treated with either cadmium or zinc.
After 6 h, we found a 2-fold increase in hepcidin protein induction
with zinc treatment compared with untreated controls or with
cadmium. Protein expression however returned to basal levels
after 24 h of zinc treatment (Fig. 7).
4. Discussion
Hepcidin has been shown to be regulated by several factors
including iron, inﬂammation and hypoxia. The transcriptional
mechanisms underlying its induction in inﬂammation are only
now beginning to be unravelled; however, its transcriptional
induction by iron remains elusive. Findings reported in this study
that treating cultured hepatocyte cell lines with iron do not have
an effect on transcription of hepcidin is in agreement with previous
reported studies. One possible explanation for this non-response of
hepcidin expression to iron in vitro is that other hepatic or extra-
hepatic cell types may be involved in this process. In pursuit of
transcriptional regulation of hepcidin by other metals, we identi-
ﬁed metal response elements within the promoter; these are
responsive to zinc, and to a lesser extent, cadmium and copper.
Induction of luciferase activity in BHK cells transfected with the
hepcidin promoter fused to a luciferase reporter gene showed that
optimal activity was zinc-dependent and occurred in a dose-
dependent manner. Other divalent metals, notably cadmium and
copper also caused an increase in luciferase activity. In BHK cells,
a cell line with attenuated MT-1 expression, it appeared that only
zinc could induce metal sensitivity fully, with minimal activity
seen after cadmium and copper exposure. The loss of functional
MT-I in this case highlights the direct effect of zinc on MTF-1 func-
tion and demonstrates the inability of other metals to activate
MTF-1 directly. It has been shown that although cadmium can in-
duce MT-1 expression by MTF-1, only zinc can activate the DNA-
binding activity of this transcription factor by its reversible interac-
tions with speciﬁc zinc ﬁngers [37–42]. This may explain why hep-
cidin mRNA expression in Huh7 cells, a cell line with normal MT-1
expression, was increased to almost the same degree after cad-
mium and copper exposure as after zinc treatment. It has previ-
ously been demonstrated in vivo that hepcidin mRNA was up-
regulated in the livers of mice fed a high copper diet [43]. The
mechanism of induction of hepcidin mRNA by both cadmium
and copper could be an indirect one, where MTF-1 is activated to
bind to MREs in the hepcidin promoter by the displacement of zinc
from MT-1 and other zinc-binding proteins. MT-1 isolated from
mouse tissues has been shown to be normally bound to zinc
[35,36]; however the afﬁnity of MT-1 for cadmium and copper is
higher [44].Since zinc regulates many genes through MTF-1/MRE interac-
tions [38], do our observations suggest that this metal may directly
regulate iron uptake and body iron stores? From what is known
about the interactions between iron and zinc (operating through
MTF-1), we conjecture that this may be the case. Another possible
explanation is that cadmium-responsive factors may be indirect
co-regulators of hepcidin expression; these proteins have been re-
ported by Koizumi et al. [37,45,46]. However, because MTF-1 is a
zinc- rather than a cadmium-sensor and binds DNA only in the
presence of zinc, this would suggest that cadmium-dependent
induction of hepcidin or MT-1 transcription may be indirect. In
other words, MTF-1 may cooperate with other transcription factors
or co-regulators in regulating hepcidin expression.
Metal response elements function synergistically and it is
thought that two or more MREs are needed for maximal promoter
inducibility by or sensitivity to zinc and MTF-1; neither the spacing
nor the orientation appears to be critical for function. Metal
responsiveness is dependent on the MRE core consensus sequence,
TGCRCNC [47,48]. The metallothioneins are archetypal proteins
that are regulated by intracellular zinc ion levels through MTF-1/
MREs interactions [38]. They are cysteine-rich, metal-binding pro-
teins involved in zinc homeostasis and heavy metal detoxiﬁcation
by binding cadmium and copper; they are also involved in protec-
tion against oxidative stress. Many genes have also been found to
have MREs present in the promoter, including ZnT-1 [49], cGCShc
[50] and other genes involved in detoxiﬁcation and general stress
response [51]. Taken together, our ﬁndings would suggest that
hepcidin may belong to this family of proteins. Intriguingly, MREs
in the MT-1 promoter differentially respond to different metals
including copper and mercury; one MRE also bound a zinc-depen-
dent co-regulator [46]. Therefore, it is possible that one or more of
the hepcidin MREs may respond to cadmium (or other metals)
depending on co-regulator type; however the overall effect of this
would be smaller than that induced by zinc. Previous studies have
shown that MTF-1 and USF1 cooperate during mouse development
to induce optimal expression of the MT-1 gene in visceral endo-
derm cells [52] and that USF1 is important in the induction of
mouse MT-1 by cadmium [53]. This may be pertinent as USF1
has been shown to be important in the transcriptional regulation
of the hepcidin gene [33].
The involvement of MREs and MTF-1 in the metal response of
hepcidin was given further credence after mutation analysis. Point
mutants of each MRE showed a decrease in zinc-dependent lucifer-
ase activity. This effect appeared to be additive as mutation of all
four MREs almost completely diminished the zinc response. How-
ever, mutating all four MREs did not reduce luciferase activity to
basal levels after zinc treatment, supporting our view that other
transcription factor(s) may synergize with MTF-1 in hepcidin re-
sponses to divalent metals. Our EMSA data also demonstrated that
zinc-treated Huh7 cells could bind to MREs in vitro; this binding
could be competitively inhibited by excess cold MRE probe.
Interestingly, our study also showed that MT-1 mRNA was up-
regulated by iron. This has been previously demonstrated in the
livers of iron-loaded rats by Brown et al. [54]; MT-1 mRNA was
up-regulated with a concomitant increase in hepcidin mRNA. A
similar effect of iron on MT-1 transcription has also been demon-
strated in vitro [55]. Although the function of MT-1 in heavy metal
detoxiﬁcation has been established, the teleology of hepcidin
induction by these metals is not clear at present but nonetheless
intriguing. Is the effect of zinc on hepcidin transcription one of pro-
tection against oxidative damage? It has been suggested that the
cytoprotective effects of MT-1 are due to its ability to release zinc
to inhibit membrane lipid peroxidation by iron [56]. Whether hep-
cidin performs a similar function remains to be tested although our
results suggest that it may also be a sensor of other metal ions
aside from iron. In other words, hepcidin may mediate cross-talk
724 S. Balesaria et al. / FEBS Letters 584 (2010) 719–725between various divalent metal ions. This study may also establish
the rationale for the immunomodulatory effects of zinc supple-
mentation [57] since this would, among others, up-regulate the
expression of hepcidin which is primarily a defensin.Acknowledgements
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